Posted on May 3, 2022
This bill is a price control bill. It says “no policy…shall impose a coinsurance, copayment, deductible, or other out-of-pocket expense for the epinephrine cartridge injector…in an amount that is greater than $25.” The immediate outcome for the consumer is a $25 price, but that is not the whole story.
The cost gets apportioned to the employer’s claims experience and that claims experience dictates the increases to the employer premium, meaning premiums will rise for all of us. Price controls do NOT…
Posted on May 3, 2022
HB 5505 is more corporate welfare. It picks winners and losers when it comes to who gets tax incentives and who doesn’t in Connecticut. Winner today: One major defense contractor. Loser: Other Connecticut business owners who don’t get such deals.
Corporate welfare is irresistible for politicians. Again, remember Henry Hazlitt’s One Lesson in Economics. Even if Sikorsky has suppliers who are helped, bottom line, corporate welfare is a special deal for special interests. It needs to stop. We need broad…
Posted on April 25, 2022
HARTFORD – State Sen. Rob Sampson (R-Wolcott) today repeated his original request to the state’s Department of Public Health Commissioner Manisha Juthani to provide clarification to college and university administrators on the immunization ‘grandfather’ clause for public school students with religious exemptions that are now entering institutions of higher education. This clause is included in Public Act No. 21-6, signed into law in April 2021.
“Unfortunately, due to conflicting [administrator] interpretations…
